| Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months |
|
|
|
|
|
|
|
|
|
| Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening |
|
|
|
|
|
|
|
|
|
| Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery |
|
|
|
|
|
|
|
|
|
| Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations |
|
|
|
|
|
|
|
|
|
| Hereditary medullary thyroid carcinoma: the management dilemma |
|
|
|
|
|
|
|
|
|
| Preimplantation genetic diagnosis for inherited breast cancer: first clinical application and live birth in Spain |
|
|
|
|
|
|
|
|
|
| RB1 mutations and second primary malignancies after hereditary retinoblastoma |
|
|
|
|
|
|
|
|
|
| Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands |
|
|
|
|
|
|
|
|
|
| Abstracts |
|
|
|
|
|
|
|
|
|
| Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families |
|
|
|
|
|
|
|
|
|
| A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad |
|
|
|
|
|
|
|
|
|
| Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome |
|
|
|
|
|
|
|
|
|
| Management of duodenal adenomatosis in FAP: single centre experience |
|
|
|
|
|
|
|
|
|
| Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients |
|
|
|
|
|
|
|
|
|
| A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours |
|
|
|
|
|
|
|
|
|
| Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer |
|
|
|
|
|
|
|
|
|
| Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance |
|
|
|
|
|
|
|
|
|
| Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors |
|
|
|
|
|
|
|
|
|
| Self-reported mammography use following BRCA1/2 genetic testing may be overestimated |
|
|
|
|
|
|
|
|
|
| Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial |
|
|
|
|
|
|
|
|
|
| Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma |
|
|
|
|
|
|
✓ |
|
Chinese |
| Patient outcomes associated with group and individual genetic counseling formats |
|
|
|
|
|
|
|
|
|
| First degree relatives and familial aggregation of gastric cancer: who to choose for control in case–control studies? |
|
|
|
|
|
|
|
|
|
| Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London |
|
|
|
|
|
|
|
|
|
| Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy |
|
|
|
|
|
|
|
|
|
| BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients |
|
|
|
|
|
|
|
|
|
| Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population |
|
|
|
|
|
|
|
|
|
| Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy |
|
|
|
|
|
|
|
|
|
| Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients |
|
|
|
|
|
|
|
|
|
| A pre-visit tailored website enhances counselees’ realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling |
|
|
|
|
|
|
|
|
|
| Introduction |
|
|
|
|
|
|
|
|
|
| Familial colorectal cancer type X syndrome: two distinct molecular entities? |
|
|
|
|
|
|
|
|
|
| A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome |
|
|
|
|
|
|
|
|
|
| Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? |
|
|
|
|
|
|
|
|
|
| LKB1 as the ghostwriter of crypt history |
|
|
|
|
|
|
|
|
|
| A survey of APC mutations in Quebec |
|
|
|
|
|
|
|
|
|
| Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan |
|
|
|
|
|
|
|
|
|
| Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors |
|
|
|
|
|
|
|
|
|
| Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A |
|
|
|
|
|
|
|
|
|
| Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints |
|
|
|
|
|
|
✓ |
|
Japanese |
| Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment |
|
|
|
|
|
|
|
|
|
| Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study |
|
|
|
|
|
|
|
|
|
| The identification and management of hereditary diffuse gastric cancer in a large Jordanian family |
|
|
|
|
|
|
|
|
|
| Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals |
|
|
|
|
|
|
|
|
|
| Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center |
|
|
|
|
|
|
|
|
|
| Familial colorectal cancer: eleven years of data from a registry program in Switzerland |
|
|
|
|
|
|
|
|
|
| The LKB1 complex-AMPK pathway: the tree that hides the forest |
|
|
|
|
|
|
|
|
|
| Peutz-Jeghers syndrome: a patient’s view |
|
|
|
|
|
|
|
|
|
| The liver: another organ involved in Muir Torre syndrome? |
|
|
|
|
|
|
|
|
|
| Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer |
|
|
|
|
|
|
|
|
|
| Factors associated with an individuals’ decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved? |
|
|
|
|
|
|
|
|
|
| Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer |
|
|
|
|
|
|
|
|
|
| A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Tunisian family with FAP |
|
|
|
|
|
|
|
|
|
| Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families |
|
|
|
|
|
|
|
|
|
| The sex ratio and age of onset features of gastric cancer patients in hereditary diffuse gastric cancer families |
|
|
|
|
|
|
|
|
|
| Cancer worry among Norwegian male BRCA1/2 mutation carriers |
|
|
|
|
|
|
|
|
|
| Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up? |
|
|
|
|
|
|
|
|
|
| A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families |
|
|
|
|
|
|
|
|
|
| The differential diagnosis of familial lentiginosis syndromes |
|
|
|
|
|
|
|
|
|
| LKB1 signaling in advancing cell differentiation |
|
|
|
|
|
|
|
|
|
| The role of LKB1 in lung cancer |
|
|
|
|
|
|
|
|
|
| The Third Birt-Hogg-Dubé Symposium, Maastricht, the Netherlands, May 11th and 12th, 2011 |
|
|
|
|
|
|
|
|
|
| Case studies in the diagnosis and management of Peutz-Jeghers syndrome |
|
|
|
|
|
|
|
|
|
| Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results |
|
|
|
|
|
|
|
|
|
| Gastrointestinal polyps and cancer in Peutz-Jeghers syndrome: clinical aspects |
|
|
|
|
|
|
|
|
|
| 12th international meeting on psychosocial aspects of hereditary cancer (IMPAHC) |
|
|
|
|
|
|
|
|
|
| Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families |
|
|
|
|
|
|
|
|
|
| Familial breast cancer: is it time to move from a reactive to a proactive role? |
|
|
|
|
|
|
|
|
|
| A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance—functional analysis reveals the pathogenic one |
|
|
|
|
|
|
|
|
|
| Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer |
|
|
|
|
|
|
|
|
|
| Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology |
|
|
|
|
|
|
|
|
|
| 4th Biennial Meeting: International Society for Gastrointestinal Hereditary Tumours |
|
|
|
|
|
|
|
|
|
| Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics |
|
|
|
|
|
|
|
|
|
| A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer |
|
|
|
|
|
|
✓ |
|
Chinese |
| Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies |
|
|
|
|
|
|
✓ |
|
German |
| A new phenotypic manifestation of familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Mutation deep within an intron of MSH2 causes Lynch syndrome |
|
|
|
|
|
|
|
|
|
| BRCA1/2 genetic testing uptake and psychosocial outcomes in men |
|
|
|
|
|
|
|
|
|
| PALB2 mutations in familial breast and pancreatic cancer |
|
|
|
|
|
|
|
|
|
| Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study |
|
|
|
|
|
|
|
|
|
| Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations |
|
|
|
|
|
|
|
|
|
| Novel germline SDHD mutation: diagnosis and implications to the patient |
|
|
|
|
|
|
|
|
|
| Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study |
|
|
|
|
|
|
|
|
|
| Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation |
|
|
|
|
|
|
|
|
|
| A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges |
|
|
|
|
|
|
|
|
|
| Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53 |
|
|
|
|
|
|
|
|
|
| Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome |
|
|
|
|
|
|
|
|
|
| Impact of computer-assisted data collection, evaluation and management on the cancer genetic counselor’s time providing patient care |
|
|
|
|
|
|
|
|
|
| German national case collection for familial pancreatic cancer (FaPaCa): ten years experience |
|
|
|
|
|
|
|
|
|